Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. scores highest on Earnings (52) and lowest on Anchor (25). Its PosiPenta is 39.93 out of 100, weaker than most similar companies.
On the Penta Grid this week, Sonoma Pharmaceuticals, Inc. is Grid #544 of 836 in the Healthcare sector in United States, and Grid #2,893 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. | 39.93 | 42 | 52 | 30 | 51 | 25 |
| Intelligent Bio Solutions Inc. | 28.26 | 40 | 46 | 10 | 23 | 22 |
| Traws Pharma, Inc. | 27.01 | 20 | 28 | 7 | 47 | 33 |
| VolitionRx Limited | 35.39 | 0 | 44 | 4 | 94 | 35 |
| Pulmatrix, Inc. | 32.18 | 30 | 25 | 27 | 59 | 21 |
| Alzamend Neuro, Inc. | 46.77 | 38 | 47 | 49 | 53 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.92 |
| P/B ratio | 0.81 |
EEarnings
| Trailing EPS | ₹-115.55 |
| Forward EPS | ₹-53.04 |
NNitro
| Price | 106.08 |
| 52-week high | 388.33 |
| 52-week low | 80.51 |
| Fall from 52-week high | 72.7% |
TTorque
| Return on equity (ROE) | -42.52% |
| Debt-to-equity | 0.11 |
AAnchor
| Beta (price swings) | 1.30 |
| Market cap | ₹50 Cr |
| Insider holding | 0.42% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sonoma Pharmaceuticals, Inc.'s PosiPenta score?
Sonoma Pharmaceuticals, Inc.'s PosiPenta is 39.93 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Sonoma Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Sonoma Pharmaceuticals, Inc. is Grid #544 of 836 in the Healthcare sector in United States, and Grid #2,893 of 3,999 in United States.
Which PosiPenta pillar is strongest for Sonoma Pharmaceuticals, Inc.?
Earnings (growth), with a score of 52 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Sonoma Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 25 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.